Article
Factors predictive of a beneficial response to therapy of hepatitis C.
Hepatology (Baltimore, Md.) - 1 Sept 1997
Davis G L, Lau J Y
Abstract excerpt
Alpha interferon is the only drug that has been shown to be effective in the treatment of chronic hepatitis C, but only half of patients respond, either transiently or permanently. Pretreatment features that are associated with a greater likelihood of response to short courses of interferon include low hepatitis C virus (HCV) RNA levels, viral genotypes 2 or 3, and the absence of fibrosis or cirrhosis on liver...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
